02.23.24 -- Cryo-Shippers: Challenges, Controls, And Logistics

To ensure that your adeno-associated virus (AAV) therapy reaches patients as soon as possible, begin your relationship with an experienced AAV manufacturer early in the development journey.

Both physical and chemical nonviral gene delivery systems for ex vivo genetic modification offer advantages over viral vectors, including smaller scale production and the low risk of immunogenicity.

Alongside the growth of monoclonal antibody use in the pharma industry, Protein A resins have undergone significant improvement that dramatic enhance process performance.

Learn how embracing digital transformation through the use of distributed automation and digital plant maturity can support productivity, efficiency, and resilience in biomanufacturing.

Explore traditional cold-wall and convection technology to determine which best suits your cold needs for upcoming projects.

Learn about the problem of immunogenicity of mRNA, modified mRNA via in vitro transcription production, and choosing fit-for-purpose modified ribonucleotides.

Evaluate a peer analysis of how a single cell dispenser helped their research team streamline the development process of single-cell clones for the cell lines they are working with.

Explore how to develop a strong packaging system and learn why a reliable supply chain is critical for drug substance and drug product transport.

Review the differences between the ICH's new draft guidance (Q14) and the traditional approach and delve deeper into the potential benefits of this methodology.